Greenrose Acquisition Corp. (GNRSW)
Greenrose Acquisition Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in DE, US. The stock last traded at $0.00, down 99.67% on the session, giving a market capitalisation of $1,768. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of 70.6%. Its beta of 3309.14 implies it has historically moved more than the broad market.
Greenrose Holding Company Inc., operating via its subsidiaries, specializes in the manufacturing and commercialization of cannabis products. Its core business functions include cultivating, processing, and packaging medicinal cannabis and its related derivative items. The organization was established in 2014 and maintains its corporate headquarters in Amityville, New York.
Greenrose Acquisition Corp. is most often compared with the following Healthcare names: